Multi-site projects include any projects that involve more than one site, institution or Centre. Each site should have its own Principal Investigator and recruit/collect data from that site.

Greater than low risk research is where the risk, even if unlikely, is more than discomfort (National Statement, 2023).

Multi-site greater than low risk applications for BH HREC review

At Barwon Health, greater than low risk research projects are reviewed by the BH HREC. Please visit the HREC page for meeting dates and submission deadlines.

If you’re not sure whether your research is suitable for a multi-site greater than low risk application, please visit the how to prepare an application page or download and complete the ‘Level of Risk Checklist‘. You may also contact rdu@barwonhealth.org.au with any queries.

Collaborating Sites – things to consider

If your collaborating sites are metro or interstate, you will need to submit your multi-site project to one of the 7 Victorian HREC ‘Reviewing’ sites:

  • Alfred Health
  • Austin Health
  • Melbourne Health
  • Peter MacCallum Cancer Centre
  • The Royal Children’s Hospital
  • Monash Health
  • St Vincent’s Hospital (Melbourne)

If your collaborating sites are regional sites, please see Regional Health Service Collaborations page for further information.

IMPORTANT NOTE: ERM does not currently facilitate BH HREC multi-site review, however by way of a workaround;

  • When preparing your submission in ERM, please select ‘single-site’. This will allow you to select Barwon Health HREC as your reviewing HREC. Ensure you list the participating sites and site PIs elsewhere within your submission. For example, within your protocol.

All application submission, feedback, correspondence, information requests and approvals occur within Ethical Review Manager (ERM).

 

Tips for completing the Ethics Application Process

  • Prior to commencing your application, review all of the items noted in the process below (including information drop-downs) before commencing with your application. Note that the numbering system is arbitrary and that multiple steps can be undertaken in parallel to save you time.
  • You can submit the research governance application at the same time as the ethics application
  • Start drafting your research agreement early (link to research agreement page)

Generate a reference number for your project via the Barwon Health Research Reference Number Generator if you have not already done so.

Please ensure that your Barwon Health reference number is quoted at the time of your submission and included on the cover page of your protocol.

For studies where Barwon Health will formally act as sponsor of a research project, including:

  • Barwon Health sponsored clinical trials (CTN/CTX clinical trials within the scope of the Therapeutic Goods Act); and
  • All Barwon Health-led multi-site studies

At least six (6) weeks before the intended submission deadline date, please email rdu@barwonhealth.org.au  with a project outline and budget.

RDU will then advise if your project will require presentation at the next Research Management Committee to secure Barwon Health sponsorship.

This process must be completed before a trial/study application can be accepted for ethics and/or governance review.

Regional multi-site project

Please refer to our document naming guidelines before submitting your application.

HREA form – complete via ERM

Must include:

Supplementary documents:

  • Supporting documents (surveys, questionnaires, etc) – these can be set up in REDCap for secure electronic data capture
  • Waiver of Consent application – please complete the Waiver of Consent Checklist to confirm requirements (downloads)
  • Authorship Record Form Template (download) – see Guidelines on Collaborative Research and Authorship
  • Details of Data Safety Monitoring Committee – click here to download Data and Safety Monitoring Board Charter template
  • For clinical trials involving drug, device or biological
    • Investigator Brochure
    • CTN/CTX – Clinical Trial Notification to TGA required for drug/device/biological trials
  • Research Involving Ionising Radiation – PI letter OR Radiation Risk Assessment (see Radiation in research guidelines page)
  • For Clinical Trials involving GMO/Gene Therapy
    • Institutional Biosafety Committee (IBC) approval
    • Licence for dealing with genetically modified organism (GMO)
  • Victorian Specific Module (VSM) – for research projects with a site in Victoria, the VSM is required document. This can be completed and submitted in ERM.

Note: If you are experiencing difficulty with ERM, please see the Victorian Clinical Trials and Research ERM training tools page.

Site Specific Assessment (SSA). Create as a subform from HREA

Include:

  • Curriculum Vitae, of all members of the research team including Site PIs and associate investigators – click for template
  • Signature by site PIs, Associate investigators and head of department – signature instructions
  • Research agreements – check the Research Agreements page to determine if required
  • Fee payment form – see Fees page to confirm requirements and applicability
  • For Deakin University led projects, an Annexure A is required. Please upload a partially executed (with DU signature) to ERM and RDU will secure Barwon Health Executive signature once the project is approved
  • Visiting Researcher Application form for all non-Barwon Health staff requesting access to identifiable BH patient data and/or requesting to come on site at BH to conduct their research project.

Submit your complete application (containing all supporting documents and signatures) via Ethics Review Manager (ERM) by clicking the ‘Submit’ button in the HREA form and SSA form

Once submitted, your application will be reviewed by the Barwon Health Human Research Ethics Committee (BH HREC). Please refer to the submission close and meeting dates of the BH HREC on the BH HREC page.

You will be prompted via email (address linked to your ERM account) to log into ERM and view any feedback, correspondence, and approvals relating to your application.

If further information is requested, you need to update the HREA form and/or upload/update any documents and re-submit your application via ERM.


Multi-site greater than low risk Governance Only applications (External HREC review)

Before beginning with a multi-site governance submission, ensure the Co-Ordinating Principal Investigator or Lead Site has created an SSA subform for Barwon Health OR provided you access to the project HREA in ERM to allow you to create an SSA subform for Barwon Health from the HREA.

Read all the points in the process (including information drop-downs) before commencing with your application. Note that the numbering system is arbitrary and that multiple steps can be undertaken in parallel to save you time.

Generate a reference number for your project via the Barwon Health Research Reference Number Generator if you have not already done so.

Please refer to our document naming guidelines before submitting your application.

Site Specific Assessment (SSA) – (ERM: select the SSA as a subform created from the HREA)

Include:

  • HREC Approval listing Barwon Health as an approved site
  • all documents listed in the HREC approval
  • Site Specific Documents – PICF, PLS, posters
  • Curriculum Vitae, of all members of the research team including Site PI and associate investigators
  • Signature by site PI, Associate investigators and head of department – signature instructions
  • Research agreements – See research agreements page to determine if required
  • Fee payment form – see Fees page to confirm requirements and applicability
  • If a Deakin University led study, an Annexure A is required. Please upload to ERM partially executed (with DU signature) and RDU will secure Barwon Health Executive signature once approved.
  • Victorian Specific Module (VSM) – for research projects with a site in Victoria, the VSM is required document.
  • Clinical Trials Only
    • Standard Form of Indemnity
    • Insurance Certificate
    • For clinical trials involving a drug, device or biological
      • Investigator Brochure
      • CTN/CTX – Clinical Trial Notification to TGA draft required
    • For clinical trials involving GMO/Gene Therapy
      • Institutional Biosafety Committee (IBC) Approval
      • Licence for dealing with genetically modified organism (GMO)
    • For clinical trials involving Radiation (see Radiation in research guidelines page)
      • Either a letter from PI stating radiation is standard of care OR Radiation Risk Assessment

Submit your complete application (containing all supporting documents and signatures) via Ethics Review Manager (ERM) by clicking the ‘Submit’ button on the SSA form.

Once submitted, your application will receive governance review by a Research Governance Officer within the RDU team. You will be prompted via email (address linked to your ERM account) to log into ERM and view any feedback, correspondence, and approvals/authorisations relating to your application. If further information is requested, you may to update the SSA form and/or upload/update any documents and re-submit your application via ERM.

Your project will also be reviewed by the Barwon Health Research Management Committee. Once approved, BH Executive research agreement signatures will be facilitated by RDU via DocuSign, and you will receive signed agreement and governance authorisation together.

Contact RDU with any queries or concerns

RDU is here to help. If you are not sure where to start or have a question regarding your research project, email us at  rdu@barwonhealth.org.au and a member of the RDU team will get back to you within 24 hours.  If you have a current application underway, please ensure you include your Barwon Health reference number in your enquiry.

For more information on submission requirements see the Victorian Clinical Trials and Research website.

Page last updated: January 21, 2025